SALIVARY OXIDATIVE STRESS BIOMARKERS AND ORAL HEALTH IN PATIENTS WITH ACTIVE INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS

Authors

  • Mihaela ROTARU Alexandru Ioan Cuza University of Iasi, Romania
  • H. MINEA Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania
  • Ana-Maria SINGEAP Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania
  • S. CHIRIAC Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania
  • A. CIOBICA Alexandru Ioan Cuza University of Iasi, Romania
  • Anca TRIFAN Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania

DOI:

https://doi.org/10.22551/

Abstract

The oral cavity and the intestine are interconnected through shared microbial and immunological pathways, supporting a bidirectional relationship between oral health and inflammatory bowel disease (IBD). Oral pathological conditions are more prevalent and severe in IBD, while oxidative stress represents a key mechanistic link between oral and intestinal inflammation. However, salivary oxidative stress biomarkers remain insufficiently characterized in IBD, and comparative data with healthy controls are limited. Materials and methods: This cross-sectional study evaluated adult participants at a single time point, who underwent standardized oral examinations and unstimulated saliva collection. Salivary oxidative stress biomarkers, including superoxide dismutase (SOD), glutathione peroxidase (GPx), malondialdehyde (MDA), and total protein levels, were assessed using validated biochemical methods. Correlation and linear regression analyses were performed to examine associations between salivary biomarkers and clinical dental indices in patients with clinically active IBD, compared with a healthy control group. Results: In patients with active IBD, salivary oxidative stress biomarkers (SOD, GPx, MDA) and total protein levels showed weak, non-significant associations with oral health indices. MDA demonstrated modest positive trends with caries experience (DMFT; r ≈ 0.45) and periodontal status (PDI; r ≈ 0.54), while SOD and GPx showed minimal correlations across oral parameters (all p > 0.05). Compared with controls, patients with IBD showed lower mean salivary SOD and GPx activities and higher MDA levels; however, these intergroup differences did not reach statistical significance. Conclusions: Salivary oxidative stress biomarkers were not significantly correlated with dental indices in patients with active IBD. Nevertheless, the observed trends for MDA suggest that lipid peroxidation may more closely reflect the shared chronic inflammatory burden affecting oral and intestinal tissues, warranting further investigation in larger, adequately powered studies.

Author Biographies

  • H. MINEA, Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania

    Institute of Gastroenterology and Hepatology,
    Sf. Spiridon County Clinical Emergency Hospital, Iasi, Romania

  • Ana-Maria SINGEAP, Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania

    Institute of Gastroenterology and Hepatology,
    Sf. Spiridon County Clinical Emergency Hospital, Iasi, Romania
    CENEMED Platform for Interdisciplinary Research, Iasi, Romania

  • S. CHIRIAC, Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania

    Institute of Gastroenterology and Hepatology,
    Sf. Spiridon County Clinical Emergency Hospital, Iasi, Romania

  • A. CIOBICA, Alexandru Ioan Cuza University of Iasi, Romania

    CENEMED Platform for Interdisciplinary Research, Iasi, Romania
    Academy of Romanian Scientists, Bucharest, Romania
    Center of Biomedical Research / Romanian Academy, Iasi Branch
    Ioan Haulica Institute / Apollonia University, Iasi, Romania

  • Anca TRIFAN, Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania

    Institute of Gastroenterology and Hepatology,
    Sf. Spiridon County Clinical Emergency Hospital, Iasi, Romania

References

1. Rowińska I, Szyperska-Ślaska A, Zariczny P, Pasławski R, Kramkowski K, Kowalczyk P. Impact of the Diet on the Formation of Oxidative Stress and Inflammation Induced by Bacterial Biofilm in the Oral Cavity. Materials (Basel) 2021; 14(6): 1372.

2. Kellermann L, Riis LB. A close view on histopathological changes in inflammatory bowel disease, a narrative review. Digestive Medicine Research 2021; 4 / doi: 10.21037/dmr-21-1.

3. Ahmed I, Roy BC, Khan SA, Septer S, Umar S. Microbiome, Metabolome and Inflammatory Bowel Disease. Microorganisms 2016; 4(2): 20.

4. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005; 366(9499):1809-1820.

5. Shazib MA, Byrd KM, Gulati AS. Diagnosis and Management of Oral Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2022; 74(1): 7-12.

6. Kuraji R, Shiba T, Dong TS, Numabe Y, Kapila YL. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis. World J Gastroenterol 2023; 29(6): 967-996.

7. Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol 2018; 16(12): 745-759.

8. Tsukasaki M, Komatsu N, Nagashima K, et al. Host defense against oral microbiota by bone-damaging T cells. Nat Commun 2018; 9(1): 701.

9. Habashneh RA, Khader YS, Alhumouz MK, Jadallah K, Ajlouni Y. The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study. J Periodontal Res 2012; 47(3): 293-298.

10. Zhou T, Xu W, Wang Q, et al. The effect of the "Oral-Gut" axis on periodontitis in inflammatory bowel disease: A review of microbe and immune mechanism associations. Front Cell Infect Microbiol 2023; 13: 1132420.

11. Ramfjord SP. The Periodontal Disease Index (PDI). J Periodontol 1967; 38(6): Suppl: 602-610.

12. Greene JC, Vermillion JR. The Simplified Oral Hygiene Index. J Am Dent Assoc 1964; 68: 7 13.

13. Moradi G, Mohamadi Bolbanabad A, et al. Evaluation of Oral Health Status Based on the Decayed, Missing and Filled Teeth (DMFT) Index. Iran J Public Health 2019; 48(11): 2050-2057.

14. Trifan A, Sfarti C, Cojocariu C, et al. Increased liver stiffness in extrahepatic cholestasis caused by choledocholithiasis. Hepat Mon 2011; 11(5): 372-375.

15. Trifan A, Stanciu C, Gheorghe L, et al. Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older. Medicine (Baltimore) 2017; 96(50): e9271.

16. Shang J, Liu H, Zheng Y, Zhang Z. Role of oxidative stress in the relationship between periodontitis and systemic diseases. Front Physiol 2023; 14: 1210449.

17. Almerich-Silla JM, Montiel-Company JM, Pastor S, Serrano F, Puig-Silla M, Dasí F. Oxidative Stress Parameters in Saliva and Its Association with Periodontal Disease and Types of Bacteria. Dis Markers 2015; 2015: 653537.

18. de Sousa Né YG, Lima WF, Mendes PFS, et al. Dental Caries and Salivary Oxidative Stress: Global Scientific Research Landscape. Antioxidants (Basel) 2023; 12(2): 330.

19. Salman BN, Darvish S, Goriuc A, et al. Salivary Oxidative Stress Markers’ Relation to Oral Diseases in Children and Adolescents. Antioxidants (Basel) 2021; 10(10): 1540.

Additional Files

Published

2026-04-01

Issue

Section

INTERNAL MEDICINE - PEDIATRICS